Review
BibTex RIS Cite

Cancer Care Management During Covid-19 Pandemic

Year 2021, Volume: 3 Issue: 1, 45 - 51, 30.04.2021

Aslıhan Öztürk Derya Çınar

https://doi.org/10.46413/boneyusbad.864878
Cited By: 1

Abstract

The Cancer patients who are newly diagnosed with cancer, whose cancer treatment (chemotherapy, radiotherapy, immunotherapy, endocrine therapy, etc.) continues or whose treatment has recently been terminated become more susceptible to infection due to the treatments. During the coronavirus disease (COVID-19) process, it has been reported that cancer patients are at higher risk, the rate of increase in morbidity and mortality may be higher, and the importance of taking necessary precautions has been reported. Ensuring the continuity of diagnosis, treatment and follow-up of cancer patients and performing infection management are of great importance in terms of preventing possible risks. Care management of cancer patients during the COVID-19 pandemic; It should be continued in accordance with the recommendations of national and international updated guidelines prepared with the aim of minimizing the risk of infection and maintaining the survival of cancer patients. During the pandemic process, appropriate strategies should be planned for the safety and health of cancer patients and oncology nurses. This article has been compiled with the aim of emphasizing the reflections of the COVID-19 pandemic process on the care of cancer patients and providing cancer care services in line with national and international current guidelines.

Keywords

Covid-19, Nursing Care, Oncology Nursing, Pandemic, Tumor

References

  • Aslan, R. (2020). Tarihten günümüze epidemiler, pandemiler ve Covid-19. Ayrıntı Dergisi, 8(85), 36-41.
  • Avdal, E.Ü. (2020). COVID-19: Komorbid durumlarda bakım yönetimi. Aykar, Ş. F., editör. İç Hastalıkları Hemşireliği ve COVID-19. 1. Baskı. Ankara: Türkiye Klinikleri, 10-14.
  • Bebitoğlu, B.T., Oğuz, E., Hodzic, A., Hatiboğlu, N., Kam, Ö. (2020). Chloroquine/ Hydroxychloroquine: pharmacological overview of an ancient drug that comes to the agenda with COVID-19 treatment. Anadolu Kliniği Tıp Bilimleri Dergisi, 25 (Özel Sayı 1), 204-215.
  • Beköz, H.S., Bilgen, H., Anak, S.S. (2020). Immune plasma therapy and its results in COVID-19 infections. Sağlık Bilimlerinde İleri Araştırmalar Dergisi, 3 (Ek Sayı 1), 68-77.
  • Berghoff, A.S., Gansterer, M., Bathke, A.C., Trutschnig, W., Hungerländer, P., Berger, J. M., … Preusser, M. (2020). SARS-CoV-2 testing in patients with cancer treated at a tertiary care hospital during the COVID-19 pandemic. Journal of Clinical Oncology, 38(30), 3547. doi: 10.1200/JCO.20.01442.
  • Bilimsel Danışma Kurulu Çalışması, S.B. (2020). COVID-19 (Sars-Cov2 Enfeksiyonu), Genel bi̇lgi̇ler, epi̇demi̇oloji̇ ve tanı. T.C. Sağlık Bakanlığı 29 Haziran 2020, Ankara, 19. https://covid19.saglik.gov.tr/Eklenti/39551/0/covid-19rehberigenelbilgilerepidemiyolojivetanipdf.pdf Erişim tarihi: 10.12.2020.
  • Burki, T.K. (2020). Cancer guidelines during the COVID-19 pandemic. The Lancet Oncology, 21(5), 629-630. doi: 10.1016/S1470-2045(20)30217-5.
  • Burstein, H. J., Griggs, J. J., Prestrud, A. A., Temin, S. (2010). American society of clinical oncology clinical practice guideline update on adjuvant endocrine therapy for women with hormone receptor–positive breast cancer. Journal of oncology practice, 6(5), 243-246. doi: 10.1200/JOP.2016.011239.
  • Cancer Care During The COVID-19 Pandemic: An ESMO Guide for Paients.
  • Çelik, D., Köse, Ş. (2020). COVID-19 in adults: clinical findings. Tepecik Eğitim ve Araştırma Hastanesi Dergisi, 30(Ek sayı), 8-43.
  • Çetintepe, S.P., İlhan, M.N. (2020). Risk Reduction in Healthcare Workers in the COVID-19 Outbreak. Journal of Biotechnology and Strategic Health Research, 1 (Özel Sayı), 50-54. doi:10.34084/bshr.712539.
  • Cinar, P., Kubal, T., Freifeld, A., Mishra, A., Shulman, L., Bachman, J., … Liu, C. (2020). Safety at the time of the COVID-19 pandemic: how to keep our oncology patients and healthcare workers safe. Journal of the National Comprehensive Cancer Network, 18(5), 504-509. doi:10.6004/jnccn.2020.7572.
  • Dai, M., Liu, D., Liu, M., Zhou, F., Li, G., Chen, Z., … Cai, H. (2020). Patients with cancer appear more vulnerable to SARS-CoV-2: A multicenter study during the COVID-19 outbreak. Cancer discovery, 10(6), 783-791. doi: 10.1158/2159-8290.CD-20-0422.
  • Dikmen, A.U., Kına, M.H., Özkan, S., İlhan, M.N. (2020). COVID-19 Epidemiology: what we learned from the pandemic. Journal of Biotechnology and Strategic Health Research, 1(Özel Sayı), 29-36. doi: 10.34084/bshr.715153.
  • European Centre for Disease Prevention and Control. Case definition and European surveillance for COVID-19, as of 2 March 2020. https://www.ecdc.europa.eu/en/covid-19/surveillance/case-definition Erişim tarihi: 26.09.2020.
  • Hatipoğlu, N. (2020). The "New" problem of humanity: new coronavirus (2019-nCoV/COVID-19) Disease. Medical Journal of Bakirkoy, 16(1), 1-8. doi: 10.5222/BMJ.2020.22931.
  • Kebudi, R. (2020). COVID-19 pandemisi ve dünyada onkolojide etkileri. Sağlık Bilimlerinde İleri Araştırmalar Dergisi, 3(S1), 99-105. doi: 10.26650/JARHS2020-S1-0013.
  • Lazzerini, M., Barbi, E., Apicella, A., Marchetti, F., Cardinale, F., Trobia, G. (2020). Delayed Access or provision of care in Italy resulting from fear of COVID-19. The Lancet Child & Adolescent Health, 4(5), e10-e11. doi: 10.1016/S2352-4642(20)30108-5.
  • Miyashita, H., Mikami, T., Chopra, N., Yamada, T., Chernyavsky, S., Rizk, D., Cruz, C. (2020). Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City. Annals of Oncology, 31(8), 1088-1089. doi: 10.1016/j.annonc.2020.04.006.
  • Paterson, C., Gobel, B., Gosselin, T., Haylock, P.J., Papadopoulou, C., Slusser, K., … Pituskin, E. (2020). Oncology nursing during a pandemic: critical reflections in the context of COVID-19. Seminars in Oncology Nursing, 36(3), 1-10. doi: 10.1016/j.soncn.2020.151028.
  • Portnoy, J., Waller, M., Elliott, T. (2020). Telemedicine in the Era of COVID-19. The Journal of Allergy and Clinical Immunology: In Practice, 8(5), 1489-1491. doi: 10.1016/j.jaip.2020.03.008.
  • Schiffer, C.A., Bohlke, K., Delaney, M., Hume, H., Magdalinski, A.J., McCullough, J.J., … Anderson, K.C. (2018). Platelet Transfusion for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 36(3), 283–299. https://doi.org/10.1200/JCO.2017.76.1734
  • Spiteri, G., Fielding, J., Diercke, M., Campese, C., Enouf, V., Gaymard, A., … Ciancio, B. C. (2020). First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 25(9), 2000178. https://doi.org/10.2807/1560-7917.ES.2020.25.9.2000178
  • Şahan, C., Özgür, E. A., Arkan, G., Alagüney, M.E., Demiral, Y. (2020). Diagnosis Guide for Occupational Disease in the COVID-19 Pandemic. İş ve Meslek Hastalıkları Uzmanları Derneği ve Halk Sağlığı Uzmanları Derneği, 1-17.
  • Şimşek, G.Ö., Çelik, P., Gülhan, E. (2020). COVID-19 Pandemisi ve Kanser. Her yönüyle COVID-19, 117-130.
  • Türk Tıbbi Onkoloji Derneği. Recommendations of Covid 19 Pandemic Advisory Board for Cancer Patients and Their Relatives. 17 Mart 2020. https://www.kanser.org/saglik/toplum/style/Covid19_hasta_onerileri.pdf Erişim tarihi: 26.09.2020.
  • World Health Organization (WHO). Global Surveillance for COVID-19 disease caused by human infection with novel coronavirus (COVID-19). https://hr.un.org/sites/hr.un.org/files/WHO-2019-nCoV-SurveillanceGuidance-2020.4-eng_0.pdf Erişim tarihi: 26.09.2020.
  • Yu, Y., Shi, Q., Zheng, P., Gao, L., Li, H., Tao, P., … Chen, H. (2020). Assessment of the quality of systematic reviews on COVID-19: A comparative study of previous coronavirus outbreaks. Journal of medical virology, 92(7), 883–890. https://doi.org/10.1002/jmv.25901
  • Zhang, L., Zhu, F., Xie, L., Wang, C., Wang, J., Chen, R., … Zhou, M. (2020). Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Annals of oncology : official journal of the European Society for Medical Oncology, 31(7), 894–901. https://doi.org/10.1016/j.annonc.2020.03.296

COVID-19 PANDEMİ SÜRECİNDE KANSER BAKIM YÖNETİMİ

Year 2021, Volume: 3 Issue: 1, 45 - 51, 30.04.2021

Aslıhan Öztürk Derya Çınar

https://doi.org/10.46413/boneyusbad.864878
Cited By: 1

Abstract

Yeni kanser teşhisi konulan, kanser tedavisi (kemoterapi, radyoterapi, immünoterapi, endokrin tedavisi vb.) devam eden veya yakın zamanda tedavisi sonlanan kanser hastaları, yapılan tedaviler nedeni ile enfeksiyona daha duyarlı hale gelmektedir. Koronavirüs hastalığı (COVID-19) sürecinde kanser hastalarının daha yüksek risk altında olduğu, morbidite ve mortalite artış hızının daha fazla olabileceği ve gerekli önlemlerin alınması gerekliliğinin önemi yapılan araştırmalarda bildirilmiştir. Kanser hastalarının tanı, tedavi ve izlemlerinin devamlılığının sağlanması ve enfeksiyon yönetiminin yapılması olası risklerin önlenmesi açısından büyük önem taşımaktadır. COVID-19 pandemi sürecinde kanser hastalarının bakım yönetimi; enfeksiyon riskini en aza indirgemek ve kanser hastalarının sağ kalımını sürdürmek amacı ile hazırlanan ulusal ve uluslararası güncel rehberlerin önerileri doğrultusunda sürdürülmelidir. Pandemi sürecinde kanser hastalarının ve onkoloji hemşirelerinin güvenliği ve sağlığı için uygun stratejiler planlanması gerekmektedir. Bu makale, COVID-19 pandemi sürecinin kanser hastalarının bakımına yansımaları ve ulusal/uluslararası güncel rehberler doğrultusunda kanser bakım hizmet sunumunu vurgulamak amacı ile derlenmiştir.

Keywords

Covid-19, Hemşirelik bakımı, Onkoloji Hemşireliği, Pandemi, Tümör

References

  • Aslan, R. (2020). Tarihten günümüze epidemiler, pandemiler ve Covid-19. Ayrıntı Dergisi, 8(85), 36-41.
  • Avdal, E.Ü. (2020). COVID-19: Komorbid durumlarda bakım yönetimi. Aykar, Ş. F., editör. İç Hastalıkları Hemşireliği ve COVID-19. 1. Baskı. Ankara: Türkiye Klinikleri, 10-14.
  • Bebitoğlu, B.T., Oğuz, E., Hodzic, A., Hatiboğlu, N., Kam, Ö. (2020). Chloroquine/ Hydroxychloroquine: pharmacological overview of an ancient drug that comes to the agenda with COVID-19 treatment. Anadolu Kliniği Tıp Bilimleri Dergisi, 25 (Özel Sayı 1), 204-215.
  • Beköz, H.S., Bilgen, H., Anak, S.S. (2020). Immune plasma therapy and its results in COVID-19 infections. Sağlık Bilimlerinde İleri Araştırmalar Dergisi, 3 (Ek Sayı 1), 68-77.
  • Berghoff, A.S., Gansterer, M., Bathke, A.C., Trutschnig, W., Hungerländer, P., Berger, J. M., … Preusser, M. (2020). SARS-CoV-2 testing in patients with cancer treated at a tertiary care hospital during the COVID-19 pandemic. Journal of Clinical Oncology, 38(30), 3547. doi: 10.1200/JCO.20.01442.
  • Bilimsel Danışma Kurulu Çalışması, S.B. (2020). COVID-19 (Sars-Cov2 Enfeksiyonu), Genel bi̇lgi̇ler, epi̇demi̇oloji̇ ve tanı. T.C. Sağlık Bakanlığı 29 Haziran 2020, Ankara, 19. https://covid19.saglik.gov.tr/Eklenti/39551/0/covid-19rehberigenelbilgilerepidemiyolojivetanipdf.pdf Erişim tarihi: 10.12.2020.
  • Burki, T.K. (2020). Cancer guidelines during the COVID-19 pandemic. The Lancet Oncology, 21(5), 629-630. doi: 10.1016/S1470-2045(20)30217-5.
  • Burstein, H. J., Griggs, J. J., Prestrud, A. A., Temin, S. (2010). American society of clinical oncology clinical practice guideline update on adjuvant endocrine therapy for women with hormone receptor–positive breast cancer. Journal of oncology practice, 6(5), 243-246. doi: 10.1200/JOP.2016.011239.
  • Cancer Care During The COVID-19 Pandemic: An ESMO Guide for Paients.
  • Çelik, D., Köse, Ş. (2020). COVID-19 in adults: clinical findings. Tepecik Eğitim ve Araştırma Hastanesi Dergisi, 30(Ek sayı), 8-43.
  • Çetintepe, S.P., İlhan, M.N. (2020). Risk Reduction in Healthcare Workers in the COVID-19 Outbreak. Journal of Biotechnology and Strategic Health Research, 1 (Özel Sayı), 50-54. doi:10.34084/bshr.712539.
  • Cinar, P., Kubal, T., Freifeld, A., Mishra, A., Shulman, L., Bachman, J., … Liu, C. (2020). Safety at the time of the COVID-19 pandemic: how to keep our oncology patients and healthcare workers safe. Journal of the National Comprehensive Cancer Network, 18(5), 504-509. doi:10.6004/jnccn.2020.7572.
  • Dai, M., Liu, D., Liu, M., Zhou, F., Li, G., Chen, Z., … Cai, H. (2020). Patients with cancer appear more vulnerable to SARS-CoV-2: A multicenter study during the COVID-19 outbreak. Cancer discovery, 10(6), 783-791. doi: 10.1158/2159-8290.CD-20-0422.
  • Dikmen, A.U., Kına, M.H., Özkan, S., İlhan, M.N. (2020). COVID-19 Epidemiology: what we learned from the pandemic. Journal of Biotechnology and Strategic Health Research, 1(Özel Sayı), 29-36. doi: 10.34084/bshr.715153.
  • European Centre for Disease Prevention and Control. Case definition and European surveillance for COVID-19, as of 2 March 2020. https://www.ecdc.europa.eu/en/covid-19/surveillance/case-definition Erişim tarihi: 26.09.2020.
  • Hatipoğlu, N. (2020). The "New" problem of humanity: new coronavirus (2019-nCoV/COVID-19) Disease. Medical Journal of Bakirkoy, 16(1), 1-8. doi: 10.5222/BMJ.2020.22931.
  • Kebudi, R. (2020). COVID-19 pandemisi ve dünyada onkolojide etkileri. Sağlık Bilimlerinde İleri Araştırmalar Dergisi, 3(S1), 99-105. doi: 10.26650/JARHS2020-S1-0013.
  • Lazzerini, M., Barbi, E., Apicella, A., Marchetti, F., Cardinale, F., Trobia, G. (2020). Delayed Access or provision of care in Italy resulting from fear of COVID-19. The Lancet Child & Adolescent Health, 4(5), e10-e11. doi: 10.1016/S2352-4642(20)30108-5.
  • Miyashita, H., Mikami, T., Chopra, N., Yamada, T., Chernyavsky, S., Rizk, D., Cruz, C. (2020). Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City. Annals of Oncology, 31(8), 1088-1089. doi: 10.1016/j.annonc.2020.04.006.
  • Paterson, C., Gobel, B., Gosselin, T., Haylock, P.J., Papadopoulou, C., Slusser, K., … Pituskin, E. (2020). Oncology nursing during a pandemic: critical reflections in the context of COVID-19. Seminars in Oncology Nursing, 36(3), 1-10. doi: 10.1016/j.soncn.2020.151028.
  • Portnoy, J., Waller, M., Elliott, T. (2020). Telemedicine in the Era of COVID-19. The Journal of Allergy and Clinical Immunology: In Practice, 8(5), 1489-1491. doi: 10.1016/j.jaip.2020.03.008.
  • Schiffer, C.A., Bohlke, K., Delaney, M., Hume, H., Magdalinski, A.J., McCullough, J.J., … Anderson, K.C. (2018). Platelet Transfusion for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 36(3), 283–299. https://doi.org/10.1200/JCO.2017.76.1734
  • Spiteri, G., Fielding, J., Diercke, M., Campese, C., Enouf, V., Gaymard, A., … Ciancio, B. C. (2020). First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 25(9), 2000178. https://doi.org/10.2807/1560-7917.ES.2020.25.9.2000178
  • Şahan, C., Özgür, E. A., Arkan, G., Alagüney, M.E., Demiral, Y. (2020). Diagnosis Guide for Occupational Disease in the COVID-19 Pandemic. İş ve Meslek Hastalıkları Uzmanları Derneği ve Halk Sağlığı Uzmanları Derneği, 1-17.
  • Şimşek, G.Ö., Çelik, P., Gülhan, E. (2020). COVID-19 Pandemisi ve Kanser. Her yönüyle COVID-19, 117-130.
  • Türk Tıbbi Onkoloji Derneği. Recommendations of Covid 19 Pandemic Advisory Board for Cancer Patients and Their Relatives. 17 Mart 2020. https://www.kanser.org/saglik/toplum/style/Covid19_hasta_onerileri.pdf Erişim tarihi: 26.09.2020.
  • World Health Organization (WHO). Global Surveillance for COVID-19 disease caused by human infection with novel coronavirus (COVID-19). https://hr.un.org/sites/hr.un.org/files/WHO-2019-nCoV-SurveillanceGuidance-2020.4-eng_0.pdf Erişim tarihi: 26.09.2020.
  • Yu, Y., Shi, Q., Zheng, P., Gao, L., Li, H., Tao, P., … Chen, H. (2020). Assessment of the quality of systematic reviews on COVID-19: A comparative study of previous coronavirus outbreaks. Journal of medical virology, 92(7), 883–890. https://doi.org/10.1002/jmv.25901
  • Zhang, L., Zhu, F., Xie, L., Wang, C., Wang, J., Chen, R., … Zhou, M. (2020). Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Annals of oncology : official journal of the European Society for Medical Oncology, 31(7), 894–901. https://doi.org/10.1016/j.annonc.2020.03.296
There are 29 citations in total.

Details

Primary Language Turkish
Subjects Health Care Administration
Journal Section REVIEW ARTICLE
Authors

Aslıhan Öztürk 0000-0002-7224-9644

Derya Çınar 0000-0002-4926-335X

Publication Date April 30, 2021
Submission Date January 19, 2021
Acceptance Date March 10, 2021
Published in Issue Year 2021 Volume: 3 Issue: 1

Cite

APA Öztürk, A., & Çınar, D. (2021). COVID-19 PANDEMİ SÜRECİNDE KANSER BAKIM YÖNETİMİ. Bandırma Onyedi Eylül Üniversitesi Sağlık Bilimleri Ve Araştırmaları Dergisi, 3(1), 45-51. https://doi.org/10.46413/boneyusbad.864878
AMA Öztürk A, Çınar D. COVID-19 PANDEMİ SÜRECİNDE KANSER BAKIM YÖNETİMİ. Bandırma Onyedi Eylül Üniversitesi Sağlık Bilimleri ve Araştırmaları Dergisi. April 2021;3(1):45-51. doi:10.46413/boneyusbad.864878
Chicago Öztürk, Aslıhan, and Derya Çınar. “COVID-19 PANDEMİ SÜRECİNDE KANSER BAKIM YÖNETİMİ”. Bandırma Onyedi Eylül Üniversitesi Sağlık Bilimleri Ve Araştırmaları Dergisi 3, no. 1 (April 2021): 45-51. https://doi.org/10.46413/boneyusbad.864878.
EndNote Öztürk A, Çınar D (April 1, 2021) COVID-19 PANDEMİ SÜRECİNDE KANSER BAKIM YÖNETİMİ. Bandırma Onyedi Eylül Üniversitesi Sağlık Bilimleri ve Araştırmaları Dergisi 3 1 45–51.
IEEE A. Öztürk and D. Çınar, “COVID-19 PANDEMİ SÜRECİNDE KANSER BAKIM YÖNETİMİ”, Bandırma Onyedi Eylül Üniversitesi Sağlık Bilimleri ve Araştırmaları Dergisi, vol. 3, no. 1, pp. 45–51, 2021, doi: 10.46413/boneyusbad.864878.
ISNAD Öztürk, Aslıhan - Çınar, Derya. “COVID-19 PANDEMİ SÜRECİNDE KANSER BAKIM YÖNETİMİ”. Bandırma Onyedi Eylül Üniversitesi Sağlık Bilimleri ve Araştırmaları Dergisi 3/1 (April 2021), 45-51. https://doi.org/10.46413/boneyusbad.864878.
JAMA Öztürk A, Çınar D. COVID-19 PANDEMİ SÜRECİNDE KANSER BAKIM YÖNETİMİ. Bandırma Onyedi Eylül Üniversitesi Sağlık Bilimleri ve Araştırmaları Dergisi. 2021;3:45–51.
MLA Öztürk, Aslıhan and Derya Çınar. “COVID-19 PANDEMİ SÜRECİNDE KANSER BAKIM YÖNETİMİ”. Bandırma Onyedi Eylül Üniversitesi Sağlık Bilimleri Ve Araştırmaları Dergisi, vol. 3, no. 1, 2021, pp. 45-51, doi:10.46413/boneyusbad.864878.
Vancouver Öztürk A, Çınar D. COVID-19 PANDEMİ SÜRECİNDE KANSER BAKIM YÖNETİMİ. Bandırma Onyedi Eylül Üniversitesi Sağlık Bilimleri ve Araştırmaları Dergisi. 2021;3(1):45-51.

Cited By

Determinants of COVID-19 cases and deaths in OECD countries
Journal of Public Health
https://doi.org/10.1007/s10389-023-01820-9
 Download Cover Image

23788 Bandırma Onyedi Eylül Üniversitesi Sağlık Bilimleri ve Araştırmaları Dergisi Creative Commons Atıf-GayriTicari 4.0 Uluslararası Lisansı ile lisanslanmıştır.